RBC Life Sciences Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2015
2016
Sales/Revenue
25,160.20
25,470.90
28,270.40
24,365.00
25,772.60
Cost of Goods Sold (COGS) incl. D&A
13,043.20
13,965.40
13,135.30
11,405.80
12,573.70
Gross Income
12,116.90
11,505.60
15,135.20
12,959.30
13,198.90
SG&A Expense
13,023.60
12,130.20
15,320.50
15,470.70
13,681.20
EBIT
906.70
624.60
185.30
2,511.40
482.30
Unusual Expense
443.10
-
-
-
-
Non Operating Income/Expense
-
-
440.00
1,706.80
184.00
Interest Expense
126.30
111.60
95.70
41.50
-
Pretax Income
589.90
736.20
721.00
846.10
666.30
Income Tax
228.50
236.20
118.20
104.30
90.00
Consolidated Net Income
361.40
500.00
602.80
741.80
756.30
Net Income
361.40
500.00
602.80
741.80
756.30
Net Income After Extraordinaries
361.40
500.00
602.80
741.80
756.30
Net Income Available to Common
361.40
500.00
602.80
741.80
756.30
EPS (Basic)
0.20
0.23
0.27
0.34
0.34
Basic Shares Outstanding
2,222.90
2,218.80
2,212.40
2,212.40
2,213.00
EPS (Diluted)
0.16
0.23
0.27
0.34
0.34
Diluted Shares Outstanding
2,222.90
2,218.80
2,212.40
2,212.40
2,213.00
EBITDA
321.90
36.30
394.60
2,009.30
67.50
About RBC Life Sciences
View Profile
